Home
Clinical Resources Search
PQI: Elacestrant (Orserdu)

Elacestrant (Orserdu)

Download PQI pdf

Last Updated: November 29, 2023

By: Michael Dean, PharmD | Kyle Kleckner, PharmD

About this PQI

The purpose of this PQI is to provide awareness of an oral estrogen receptor antagonist option for patients undergoing treatment for breast cancer and to discuss counseling, monitoring parameters, and patient management strategies to optimize adherence and improve patient outcomes.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Elacestrant (Orserdu)

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

PQI: Encorafenib (Braftovi) + Cetuximab (Erbitux) + FOLFIRI for BRAF V600E-Positive Metastatic Colorectal Cancer

PQI: Reflex Biomarker Testing in Metastatic Colorectal Cancer: Implementing BRAF and MSI Assessment

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E7: Your Health Story in One Place

S11 E6: Finding the Heart of Oncology

S11 E5: Keep Marching On: Changing the Story of Pancreatic Cancer

S11 E4: From Data to Decisions: Decoding Prostate Cancer Updates

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Palbociclib and Trastuzumab

Palbociclib, Trastuzumab, and Pertuzumab

Gedatolisib

Carboplatin and Docetaxel

Understanding Hormonal Side Effects During Cancer Treatment

Elacestrant

Elacestrant

Melphalan Conditioning for Autologous Transplant

Carmustine, Etoposide, Cytarabine, and Melphalan

Talquetamab, Pomalidomide and Daratumumab/Hyaluronidase

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma